Threonyl-tRNA synthetase overexpression correlates with angiogenic markers and progression of human ovarian cancer
Autor: | Karen M. Lounsbury, Cheung Wong, Midori Eckenstein, Christopher S. Francklyn, Takamaru Ashikaga, Sharon L. Mount, Mercedes Rincon, Theresa L. Wellman |
---|---|
Rok vydání: | 2014 |
Předmět: |
Vascular Endothelial Growth Factor A
Multivariate Cox analysis Cancer Research tRNA synthetase Angiogenesis viruses Carcinoma Ovarian Epithelial Biology complex mixtures 03 medical and health sciences 0302 clinical medicine Immune system Surgical oncology Cell Line Tumor otorhinolaryngologic diseases Biomarkers Tumor Threonine-tRNA Ligase Genetics medicine Protein biosynthesis Extracellular Humans Neoplasms Glandular and Epithelial 030304 developmental biology Ovarian Neoplasms 0303 health sciences Tumor microenvironment Neovascularization Pathologic Tumor Necrosis Factor-alpha Serous papillary ovarian cancer medicine.disease Database analysis Survival Analysis 3. Good health Oncology 030220 oncology & carcinogenesis Immunology Cancer research Female Stem cell Ovarian cancer Research Article |
Zdroj: | BMC Cancer |
ISSN: | 1471-2407 |
DOI: | 10.1186/1471-2407-14-620 |
Popis: | Background Ovarian tumors create a dynamic microenvironment that promotes angiogenesis and reduces immune responses. Our research has revealed that threonyl-tRNA synthetase (TARS) has an extracellular angiogenic activity separate from its function in protein synthesis. The objective of this study was to test the hypothesis that TARS expression in clinical samples correlates with angiogenic markers and ovarian cancer progression. Methods Protein and mRNA databases were explored to correlate TARS expression with ovarian cancer. Serial sections of paraffin embedded ovarian tissues from 70 patients diagnosed with epithelial ovarian cancer and 12 control patients were assessed for expression of TARS, vascular endothelial growth factor (VEGF) and PECAM using immunohistochemistry. TARS secretion from SK-OV-3 human ovarian cancer cells was measured. Serum samples from 31 tissue-matched patients were analyzed by ELISA for TARS, CA-125, and tumor necrosis factor-α (TNF-α). Results There was a strong association between the tumor expression of TARS and advancing stage of epithelial ovarian cancer (p |
Databáze: | OpenAIRE |
Externí odkaz: |